Can AI make doctors obsolete? Yes and no

While some believe AI’s increased role in medicine can result in physicians becoming obsolete, others don’t believe AI or machines will ever be able to deal with the social factors that go into illnesses. Three researchers argued both sides in a head-to-head commentary piece recently published in The BMJ.

Jorg Goldhahn, deputy head of the Institute for Translational Medicine at ETH Zurich in Switzerland, argued that AI has the potential to be more accurate than doctors, causing them to eventually become obsolete. AI systems have a “near unlimited capacity” for data processing, learning and self-correction and can do so at a speed humans can’t match, he noted.

AI systems also have the ability to be more accurate at making diagnoses in some specialties, more reliable, less biased and less unstable than physicians, while also being a cheaper solution in a healthcare industry that’s continuing to see rising costs, he said.  

“Doctors as we now know them will become obsolete eventually. In the meantime, we should expect stepwise introduction of AI technology in promising areas, such as image analysis or pattern recognition, followed by proof of concept and demonstration of added value for patients and society,” Goldhahn concluded. “This will lead to broader use of AI in more specialties and, sooner than we think, human doctors will merely assist AI systems. These systems will not be perfect, but they will be constantly perfecting themselves and will outperform human physicians in many ways.”

Though other researchers––Vanessa Rampton, with the McGill Institute for Health and Social Policy, and Giatgen A. Spinas, emeritus professor with the University Hospital in Zurich––understand the potential of AI, they don’t believe it will ever be able to replicate the intimacy of the patient-doctor relationship.

“There are no algorithms for such situations, which change depending on emotions, non-verbal communication, values, personal preferences, prevailing social circumstances, and so on. Those working at the cutting edge of AI in medicine acknowledge that AI approaches are not designed to replace human doctors entirely,” Rampton and Spinas wrote.

The two argued that machines can augment the tasks of physicians but will never be able to replace them entirely, because physicians will always be better at dealing with the patient as a whole person. Additionally, they said AI reaches its limits when its confronted with emotional, social and non-quantifiable factors that contribute to illness.

“A likely future scenario will be AI systems augmenting knowledge production and processing, and doctors helping patients find an equilibrium that acknowledges the limitations of the human condition, something that is inaccessible to AI,” the two concluded. “Coping with illness often does not include curing illness, and here doctors are irreplaceable.”

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.